Labour Analgesia; Comparing a Combinations of Either Fentanyl or Bupivacaine With Intrathecal Morphine
- Conditions
- Labor Pain
- Interventions
- Drug: Intrathecal morphine with fentanylDrug: Intrathecal morphine with bupivacaine
- Registration Number
- NCT02498171
- Lead Sponsor
- Makerere University
- Brief Summary
This study is aimed at evaluating single short spinal technique as a form of labour analgesia in a setting where more expensive and labor intensive techniques are not feasible.The study will examine the safety and efficacy of two drug combinations (intrathecal morphine+fentanyl vs intrathecal morphine+bupivacaine) through a randomized control trial.
The investigators hypothesize that a single shot of either intrathecal morphine plus fentanyl or intrathecal morphine plus bupivacaine achieve analgesia and are safe in parturients experiencing normal labour.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 138
- Parturients with singleton pregnancy
- Emancipated minors
- Those who declined.
- Parturients with any identified complication of labour like preeclampsia, severe cardiac disease or previous operative delivery.
- Sepsis or wound at site of spinal injection.
- Allergy to any of the study drugs elicited from history.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intrathecal morphine with fentanyl Intrathecal morphine with fentanyl Single shot of intrathecal morphine 100mcg mixed with 25mcg of fentanyl and filled up to make a 2ml solution. This would then be injected into the subarachnoid space through L2-3 or L3-4 following standard procedures. Intrathecal morphine with bupivacaine Intrathecal morphine with bupivacaine Single shot of intrathecal morphine 100mcg mixed with 2.5mg of spinal bupivacaine and filled up to make a 2ml solution.This would then be injected into the subarachnoid space through L2-3 or L3-4 following standard procedures.
- Primary Outcome Measures
Name Time Method Duration of analgesia 10 hours Monitoring the level of pain by the visual analogue scale to determine the total duration of analgesia in hours starting 5 min after drug administration
- Secondary Outcome Measures
Name Time Method APGAR score 6 minutes The effect of the drugs to the fetus shall be determined by proxy from the APGAR scores of the baby determined at 1 minute and then at 5 minutes. Poor APGAR scores are those equal or less than seven (7).
Maternal side effects (composite) 34 hours Maternal side effects including pruritis, urinary retention, high Bromage score, nausea and vomiting, abnormal blood pressure and pulse rate will be ascertained 24 hours after delivery.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.